Moody's says may review M&As if new tax rules lead to altered terms
September 23, 2014 at 18:34 PM EDT
Sept 23 (Reuters) - Moody's Investors Service said it may review the credit implications for pending tax-inversion deals in the healthcare and pharmaceutical sector if U.S. Treasury's new rules force companies to alter deal terms.
